Cushman & Wakefield has appointed Rory MacGregor as head of science and innovation.
MacGregor, who is based in London, previously led the firm’s science and innovation capital markets offering and has been advising clients on investment transactions across the UK and EMEA.
In his new role, he will work closely with Charles Dady, head of national office agency, and David Hutchings, head of investment strategy, EMEA capital markets.
MacGregor said: “Cushman & Wakefield’s global reach, combined with our local market and sector specialist expertise, allows us to provide our occupier and investor clients with holistic, multidisciplinary advice. Recent improvements across the US life sciences landscape, reflected in multi-year highs on the public XBI index tracking US biotech share prices, offer encouraging signals for global and UK market conditions heading into 2026.”
Dady added: “There are a number of positive indicators for an improving science and innovation sector, and we are delighted to announce Rory’s appointment to head the team at this pivotal period in the market. He brings considerable transactional and professional experience in the sector, at a time when investors are raising new funds and more occupiers are looking for advice on their real estate strategies.”
